{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T04:20:03Z","timestamp":1726806003115},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vascn.2024.107543","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T06:07:43Z","timestamp":1721023663000},"page":"107543","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessment of corrected JT-peak (JTpc) and Tpeak-to-Tend (TpTec) as proarrhythmia biomarkers in non-human primates: Outcome from a HESI consortium"],"prefix":"10.1016","volume":"129","author":[{"given":"Emmanuel","family":"Boulay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Authier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Bartko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Greiter-Wilke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Leishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill V.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric I.","family":"Rossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Walisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Troncy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"Wisialowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2024.107543_bb0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/dmd.109.028829","article-title":"A comparison of pharmacokinetics between humans and monkeys","volume":"38","author":"Akabane","year":"2010","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.vascn.2024.107543_bb0010","series-title":"Comprehensive toxicology","first-page":"383","article-title":"Iatrogenic QT prolongation","volume":"Vol. 13","author":"Bialecki","year":"2018"},{"key":"10.1016\/j.vascn.2024.107543_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1091581818813601","article-title":"A proof-of-concept evaluation of JTPc and Tp-Tec as proarrhythmia biomarkers in preclinical species: A retrospective analysis by an HESI-sponsored consortium","volume":"38","author":"Boulay","year":"2019","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.vascn.2024.107543_bb0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/1091581820954865","article-title":"Confounders and pharmacological characterization when using the QT, JTp, and Tpe intervals in beagle dogs","volume":"39","author":"Boulay","year":"2020","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.vascn.2024.107543_bb0025","article-title":"In silico human cardiomyocyte action potential modeling: Exploring ion channel input combinations","volume":"0","author":"Boulay","year":"2024","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.vascn.2024.107543_bb0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0735-1097(95)00234-U","article-title":"Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes","volume":"26","author":"Chezalviel-Guilbert","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.vascn.2024.107543_bb0035","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jelectrocard.2017.08.018","article-title":"The algorithmic performance of J-Tpeak for drug safety clinical trial","volume":"50","author":"Chien","year":"2017","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2024.107543_bb0040","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jelectrocard.2017.07.011","article-title":"The J to T-peak interval as a biomarker in drug safety studies: A method of accuracy assessment applied to two algorithms","volume":"50","author":"Chiu","year":"2017","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2024.107543_bb0045","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jelectrocard.2017.08.025","article-title":"An evaluation of multiple algorithms for the measurement of the heart rate corrected JTpeak interval","volume":"50","author":"Couderc","year":"2017","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2024.107543_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107543_bb0055","first-page":"617","article-title":"Mexiletine-quinidine combination: Enhanced antiarrhythmic and electrophysiologic activity in the dog","volume":"249","author":"Duff","year":"1989","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2024.107543_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1266084","article-title":"Machine learning approach to evaluate TdP risk of drugs using cardiac electrophysiological model including inter-individual variability","volume":"14","author":"Fuadah","year":"2023","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.vascn.2024.107543_bb0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2015.34","article-title":"Evolution of strategies to improve preclinical cardiac safety testing","volume":"15","author":"Gintant","year":"2016","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.vascn.2024.107543_bb0070","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fphys.2019.00934","article-title":"Detection of T wave peak for serial comparisons of JTp interval","volume":"10","author":"Hnatkova","year":"2019","journal-title":"Frontiers in Physiology"},{"author":"ICH","key":"10.1016\/j.vascn.2024.107543_bb0075"},{"author":"ICH","key":"10.1016\/j.vascn.2024.107543_bb0080"},{"author":"ICH","key":"10.1016\/j.vascn.2024.107543_bb0085"},{"key":"10.1016\/j.vascn.2024.107543_bb0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/clpt.2013.238","article-title":"Improving the assessment of heart toxicity for all new drugs through translational regulatory science","volume":"95","author":"Johannesen","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107543_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166925","article-title":"Automated algorithm for J-Tpeak and Tpeak-tend assessment of drug-induced proarrhythmia risk","volume":"11","author":"Johannesen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2024.107543_bb0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cpt.205","article-title":"Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial","volume":"99","author":"Johannesen","year":"2016","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107543_bb0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: Randomized study of dofetilide, quinidine, ranolazine, and verapamil","volume":"96","author":"Johannesen","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107543_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2004.06.003","article-title":"Variability in the measurement of hERG potassium channel inhibition: Effects of temperature and stimulus pattern","volume":"50","author":"Kirsch","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107543_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106606","article-title":"Exposure-response analysis of drug-induced QT interval prolongation in telemetered monkeys for translational prediction to human","volume":"99","author":"Komatsu","year":"2019","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107543_bb0120","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: Superior to the HERG model in predicting torsade de pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2024.107543_bb0125","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.ijcard.2013.07.136","article-title":"The impact of drug-related QT prolongation on FDA regulatory decisions","volume":"168","author":"Park","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.vascn.2024.107543_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2024.107543_bb0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/toxsci\/45.2.247","article-title":"The heart rate-corrected QT interval of conscious beagle dogs: A formula based on analysis of covariance","volume":"45","author":"Spence","year":"1998","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2024.107543_bb0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/cpt.2137","article-title":"Translational models and tools to reduce clinical trials and improve regulatory decision making for QTc and proarrhythmia risk (ICH E14\/S7B updates)","volume":"109","author":"Strauss","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107543_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfac013","article-title":"The challenges of predicting drug-induced QTc prolongation in humans","volume":"187","author":"Valentin","year":"2022","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2024.107543_bb0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cpt.2029","article-title":"Time for a fully integrated nonclinical-clinical risk assessment to streamline QT prolongation liability determinations: A pharma industry perspective","volume":"109","author":"Vargas","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107543_bb0155","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jelectrocard.2017.08.003","article-title":"Electrocardiographic biomarkers to confirm drug\u2019s electrophysiological effects used for proarrhythmic risk prediction under CiPA","volume":"50","author":"Vicente","year":"2017","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2024.107543_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001615","article-title":"Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil","volume":"4","author":"Vicente","year":"2015","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.vascn.2024.107543_bb0165","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jcph.1411","article-title":"The potential role of the J-T(peak) interval in proarrhythmic cardiac safety: Current state of the science from the American college of clinical pharmacology and the cardiac safety research consortium","volume":"59","author":"Vicente","year":"2019","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2024.107543_bb0170","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cpt.1303","article-title":"Assessment of multi-ion channel block in a phase I randomized study design: Results of the CiPA phase I ECG biomarker validation study","volume":"105","author":"Vicente","year":"2019","journal-title":"Clinical Pharmacology and Therapeutics"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T11:29:57Z","timestamp":1726745397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871924000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"alternative-id":["S1056871924000534"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107543","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of corrected JT-peak (JTpc) and Tpeak-to-Tend (TpTec) as proarrhythmia biomarkers in non-human primates: Outcome from a HESI consortium","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107543"}}